Bone Health: Ipamorelin shows promise in enhancing bone mineral density, which is beneficial for individuals with conditions like osteoporosis or those looking to maintain optimal bone health
Baseline characteristics Both groups were broadly similar in terms of BMI, RA duration, and the use of conventional, biologic, or targeted synthetic disease-modifying antirheumatic drugs (DMARDs)
GLP-1R + ChAT + neurons were also observed in the other two autonomic nuclei, the ICN and CAA
GLP-1 is a body and fit shift
Biomarker Context and Precision Therapy Considerations Beyond standard dosage charts, biomarker and genetic data can provide additional context for personalizing GLP-1 therapy
GLP-1 Receptor Agonist Discontinuation Among Patients with Obesity and/or Type 2 Diabetes